AVEO

Aveo Pharmaceuticals Inc

A biopharmaceutical company focused on targeted cancer therapies, AVEO makes Fotivda (tivozanib), an FDA-approved pill used by adults with advanced kidney cancer whose disease has returned after earlier treatments. Founded in 2001 as GenPath Pharmaceuticals and renamed AVEO in 2005, it is now a wholly owned subsidiary of LG Chem and operates as AVEO Oncology. Its name hints at its mission: helping cancer patients move forward while keeping up daily life.

No 8-K or 6-K filings recorded.